Table 1.
Serious adverse clinical events in older and young HIV-infected participants during 192 weeks of observation.
| Clinical events | Number of events
|
P value | |
|---|---|---|---|
| Older | Young | ||
| Cardiovascular | 0.049 | ||
| Hypertension | 5 | 2 | |
| Peripheral vascular disease | 2 | 0 | |
| Heart disease | 2 | 0 | |
| Total | 9 | 2 | |
| Diabetes | 3 | 0 | 0.24 |
| HIV-associated or death | 0.14 | ||
| Pneumocystis jorovecci | 1 | 0 | |
| Cryptococcal meningitis | 0 | 1 | |
| Toxoplasmic encephalitis | 0 | 1 | |
| AIDS wasting | 1 | 0 | |
| Esophageal candidiasis | 1 | 1 | |
| HIV-associated myelopathy | 1 | 0 | |
| Non Hodgkin’s lymphoma | 1 | 1 | |
| HIV-associated nephropathy | 1 | 0 | |
| Anogenital neoplasia | 1 | 0 | |
| Othera | 1 | 0 | |
| Death | 2 | 0 | |
| Total | 10 | 4 | |
a
Central nervous system mass lesion of undetermined cause.